In Depth 8 Apr 2024
A wave of biotech layoffs: will the trend continue throughout 2024?
Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe.
Mergers & acquisitions
- Latest Posts
In Depth 21 Mar 2024
Biotech in France: What’s holding back progress and how to move forward?
Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector.
In Depth 18 Mar 2024
Will the US biotech funding surge trigger a renaissance in the global biotech industry?
After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick.
In Depth 11 Mar 2024
Biotech bankruptcies: what to expect in 2024 following a record year?
2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024?
In Depth 7 Mar 2024
Can AbbVie’s legacy live beyond its once best-selling drug Humira?
The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.
Best in Biotech 5 Mar 2024
Fourteen biotech companies with market caps exceeding $100 billion
Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs.
ADVERTISEMENT
ADVERTISEMENT
In Depth 27 Feb 2024
Can the Novo Holdings-Catalent deal set a new standard for Pharma M&A?
Explore the strategic implications of Novo Nordisk’s $16.5B Catalent acquisition on drug supply and market competition.
In Depth 9 Feb 2024
Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
In Depth 25 Jan 2024
The trends that will shape the biotech industry in 2024
What does 2024 hold for the biotech industry? Delve into the experts’ insight on the biotech trends that will shape 2024.
News and Trends 8 Jan 2024
Is the biotech industry poised for recovery in 2024?
The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.
Weekly Roundup 15 Dec 2023
Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news.
ADVERTISEMENT
